MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results